• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺黏液性与非黏液性混合浸润性腺癌伴血行转移至多个器官。

Mixed invasive mucinous and non-mucinous adenocarcinoma of the lung with hematogenous metastases to multiple organs.

作者信息

Otsuka Shinya, Hiraoka Kei, Iwashiro Nozomu, Kimura Noriko, Ohara Masanori

机构信息

Department of Surgery, National Hospital Organization (NHO) Hakodate National Hospital, Hakodate, Hokkaido, Japan.

Department of Diagnostic Pathology, NHO Hakodate National Hospital, Hakodate, Hokkaido, Japan.

出版信息

Respir Med Case Rep. 2024 May 1;49:102033. doi: 10.1016/j.rmcr.2024.102033. eCollection 2024.

DOI:10.1016/j.rmcr.2024.102033
PMID:38737835
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11081798/
Abstract

Mixed invasive mucinous and non-mucinous adenocarcinoma is a rare variant of lung adenocarcinoma. In pure invasive mucinous adenocarcinoma, multilobar and bilateral involvement are common, and extrathoracic metastasis is rare. Here, we report a case of mixed invasive mucinous and non-mucinous adenocarcinoma with distant metastasis to multiple organs without marked enlargement of the primary lung lesion. The pathological findings indicated high tumor invasiveness and the patient died 10 months after diagnosis despite chemoimmunotherapy. Further investigations are necessary to elucidate the clinical characteristics and appropriate management of mixed invasive mucinous and non-mucinous adenocarcinoma.

摘要

混合性浸润性黏液性和非黏液性腺癌是肺腺癌的一种罕见变异型。在纯浸润性黏液性腺癌中,多叶和双侧受累常见,而胸外转移罕见。在此,我们报告一例混合性浸润性黏液性和非黏液性腺癌,发生多器官远处转移,而原发性肺病灶无明显增大。病理结果显示肿瘤侵袭性高,尽管进行了化疗免疫治疗,患者在诊断后10个月死亡。有必要进一步研究以阐明混合性浸润性黏液性和非黏液性腺癌的临床特征及合适的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adc6/11081798/e6c326229805/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adc6/11081798/618e5d2a2e3e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adc6/11081798/57705d4b22d8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adc6/11081798/3296d0f2cf45/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adc6/11081798/09437d641816/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adc6/11081798/e6c326229805/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adc6/11081798/618e5d2a2e3e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adc6/11081798/57705d4b22d8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adc6/11081798/3296d0f2cf45/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adc6/11081798/09437d641816/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adc6/11081798/e6c326229805/gr5.jpg

相似文献

1
Mixed invasive mucinous and non-mucinous adenocarcinoma of the lung with hematogenous metastases to multiple organs.肺黏液性与非黏液性混合浸润性腺癌伴血行转移至多个器官。
Respir Med Case Rep. 2024 May 1;49:102033. doi: 10.1016/j.rmcr.2024.102033. eCollection 2024.
2
[Construction of a Prognostic Prediction Model of Patients with Pathologic N0 
in Resected Invasive Mucinous Adenocarcinoma of the Lung].[肺浸润性黏液腺癌切除术后病理N0患者预后预测模型的构建]
Zhongguo Fei Ai Za Zhi. 2024 Jan 20;27(1):47-55. doi: 10.3779/j.issn.1009-3419.2024.106.02.
3
Acinar with ductal and mucinous adenocarcinoma of prostate cancer complicated with lung metastasis: a case report and literature review.前列腺癌腺泡伴导管及黏液腺癌合并肺转移:1例报告及文献复习
Ann Palliat Med. 2021 Feb;10(2):2366-2370. doi: 10.21037/apm-20-386. Epub 2020 Jun 23.
4
Left testicular and pulmonary metastases of mucinous adenocarcinoma of the prostate after robot-assisted radical prostatectomy.机器人辅助根治性前列腺切除术后前列腺黏液腺癌的左侧睾丸及肺转移
IJU Case Rep. 2023 Apr 13;6(4):222-225. doi: 10.1002/iju5.12591. eCollection 2023 Jul.
5
Comparison of the immunotherapy efficacy between invasive mucinous and non-mucinous adenocarcinoma in advanced lung cancer patients with KRAS mutation: a retrospective study.KRAS 突变型晚期肺癌患者侵袭性黏液性腺癌与非黏液性腺癌免疫治疗疗效比较:一项回顾性研究。
Med Oncol. 2023 Jun 9;40(7):198. doi: 10.1007/s12032-023-02059-w.
6
Anaplastic lymphoma kinase fusion protein expression is associated with a favorable prognosis in resected invasive mucinous lung adenocarcinoma: A retrospective study from two Chinese tertiary hospitals.间变性淋巴瘤激酶融合蛋白表达与切除的侵袭性黏液性腺癌的良好预后相关:来自两家中国三甲医院的回顾性研究。
J Cancer Res Ther. 2022 Apr;18(2):445-451. doi: 10.4103/jcrt.jcrt_2334_21.
7
Solitary Nodular Invasive Mucinous Adenocarcinoma of the Lung: Imaging Diagnosis Using the Morphologic-Metabolic Dissociation Sign.肺孤立性结节状侵袭性黏液性腺癌:基于形态-代谢分离征象的影像诊断。
Korean J Radiol. 2019 Mar;20(3):513-521. doi: 10.3348/kjr.2018.0409.
8
Pulmonary invasive mucinous adenocarcinoma.肺浸润性黏液腺癌。
Histopathology. 2024 Jan;84(1):18-31. doi: 10.1111/his.15064. Epub 2023 Oct 22.
9
Pulmonary invasive mucinous adenocarcinoma and mixed invasive mucinous/nonmucinous adenocarcinoma-a clinicopathological and molecular genetic study with survival analysis.肺浸润性黏液性腺癌及混合性浸润性黏液/非黏液性腺癌——一项临床病理和分子遗传学研究并结合生存分析。
Hum Pathol. 2018 Jan;71:8-19. doi: 10.1016/j.humpath.2017.08.002. Epub 2017 Aug 17.
10
Pulmonary invasive mucinous adenocarcinoma mimicking pulmonary actinomycosis.肺浸润性黏液性腺癌,类似于肺放线菌病。
BMC Pulm Med. 2022 May 6;22(1):181. doi: 10.1186/s12890-022-01971-7.

本文引用的文献

1
Invasive mucinous adenocarcinoma of the lung.肺浸润性黏液腺癌
Transl Cancer Res. 2019 Dec;8(8):2924-2932. doi: 10.21037/tcr.2019.11.02.
2
Biology of invasive mucinous adenocarcinoma of the lung.肺侵袭性黏液腺癌的生物学
Transl Lung Cancer Res. 2017 Oct;6(5):508-512. doi: 10.21037/tlcr.2017.06.10.
3
Pulmonary invasive mucinous adenocarcinoma and mixed invasive mucinous/nonmucinous adenocarcinoma-a clinicopathological and molecular genetic study with survival analysis.肺浸润性黏液性腺癌及混合性浸润性黏液/非黏液性腺癌——一项临床病理和分子遗传学研究并结合生存分析。
Hum Pathol. 2018 Jan;71:8-19. doi: 10.1016/j.humpath.2017.08.002. Epub 2017 Aug 17.
4
Clinicopathological and immunohistochemical features of lung invasive mucinous adenocarcinoma based on computed tomography findings.基于计算机断层扫描结果的肺浸润性黏液腺癌的临床病理及免疫组化特征
Onco Targets Ther. 2016 Dec 28;10:153-163. doi: 10.2147/OTT.S121059. eCollection 2017.
5
Prognosis in Resected Invasive Mucinous Adenocarcinomas of the Lung: Related Factors and Comparison with Resected Nonmucinous Adenocarcinomas.肺浸润性黏液腺癌的预后:相关因素及与肺非黏液腺癌的比较。
J Thorac Oncol. 2016 Jul;11(7):1064-73. doi: 10.1016/j.jtho.2016.03.011. Epub 2016 Mar 22.
6
Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung.肺浸润性黏液腺癌的独特遗传和生存特征。
J Thorac Oncol. 2015 Aug;10(8):1156-62. doi: 10.1097/JTO.0000000000000579.
7
Relation between thin-section computed tomography and clinical findings of mucinous adenocarcinoma.黏液腺癌的薄层计算机断层扫描与临床发现之间的关系。
Ann Thorac Surg. 2015 Mar;99(3):975-81. doi: 10.1016/j.athoracsur.2014.10.065. Epub 2015 Jan 24.
8
Associations between mutations and histologic patterns of mucin in lung adenocarcinoma: invasive mucinous pattern and extracellular mucin are associated with KRAS mutation.肺腺癌中黏蛋白突变与组织学模式之间的关联:浸润性黏液模式和细胞外黏蛋白与KRAS突变相关。
Am J Surg Pathol. 2014 Aug;38(8):1118-27. doi: 10.1097/PAS.0000000000000246.
9
Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients.验证 IASLC/ATS/ERS 肺腺癌分类对预后的影响及其与 EGFR 和 KRAS 基因突变的关系:440 例日本患者的分析。
J Thorac Oncol. 2013 Jan;8(1):52-61. doi: 10.1097/JTO.0b013e3182769aa8.